Published in Respiratory Therapeutics Week, September 4th, 2006
According to recent research from Germany, "LSM supplies in vivo information from epithelia up to depths between 0.1 to 0.5 mm. The aim of this ex vivo prospective pilot study was to investigate the potential use of LSM for the diagnosis of laryngeal cancer and its precursors."
T. Just and colleagues, University of Rostock, wrote, "Forty-three larynx specimens of 26 patients (age 35-61 years, mean age 51.9±9.5 years; 7 women and 19 men) with laryngeal lesions were investigated with LSM. The LSM findings were compared with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week